Dev Labtech Venture Limited (DEVLAB) Fair Value & Analysis
Consumer Cyclical · IN · Market cap ₹957M
Fair value as of: Jul 5, 2026
From 15 valuation models · updated today
Share price −27.0% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹15.01 – ₹31.50 · fair‑value band ₹25.71 – ₹42.85 · the ₹20.17 price screens below the ₹34.28 fair value. As of Jul 5, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Dev Labtech Venture Limited (DEVLAB) currently trades at ₹20.17, while our model-based Fair Value estimate is ₹34.28 — implying the stock looks roughly 70.0% undervalued today. We read business quality at 44/100 (below-average quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Dev Labtech Venture Limited generated revenue of ₹1.7B at a net margin of 5.7%. Revenue grew 258.5% year over year. It earns a return on equity of 20.8%. Net debt stands at ₹28.7M. Fundamentals as of Jul 5, 2026
Our scenario range runs from ₹25.71 (bear case) to ₹42.85 (bull case); at ₹20.17, the current price sits below that range. The share trades about 36% below its 52-week high and 47% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at -37% fair-value upside — at 70%, DEVLAB screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.
About the company
Dev Labtech Venture Limited manufactures, wholesales, and trades in polished and lab grown diamonds in India. It offers natural diamonds for use in jewelry and ornaments, and industrial cutting tools; and lab grown diamonds for use in jewelry, as well as machining and cutting tools, thermal conductor, optical material, electronics, semi-conductors, electronic industries, etc.; and chemical vapor deposition diamonds. The company also provides its products through its online platform. In addition, it exports its products to the United States and Hong Kong. The company was incorporated in 1993 and is headquartered in Bhavnagar, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Dev Labtech Venture Limited reported revenue of ₹1.7B in FY2026 versus ₹269M in FY2022, a compound +58.0%/yr. Reported net income was ₹95.7M in FY2026, compounding +109.8%/yr from FY2022.
Is DEVLAB fairly valued? → Check now
Similar stocks
10 more Luxury Goods stocks, each showing price versus our Fair Value estimate (as of Jul 5, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| LVMH Moët Hennessy - Louis Vuitton, Société Européenne, LVMUY | $110.06 | $106.54 | -3% |
| Hermès International Société en commandite par actions HESAY | $184.96 | $105.66 | -43% |
| Compagnie Financière Richemont SA CFRHF | $225.92 | $143.35 | -37% |
| Christian Dior SE CHDRY | $129.80 | $151.76 | +17% |
| Titan Company TITAN | ₹4,260 | ₹1,546 | -64% |
| Kering SA PPRUF | $302.02 | $68.89 | -77% |
| Tapestry, Inc TPR | $149.20 | $19.95 | -87% |
| Chow Tai Fook Jewellery Group 1929 | HK$11.27 | HK$13.19 | +17% |
| The Swatch Group UHR | CHF 216.20 | CHF 80.67 | -63% |
| Prada S.p.A PRDSF | $4.75 | $8.00 | +68% |
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is Dev Labtech Venture Limited (DEVLAB) undervalued?
What is the fair value of DEVLAB?
What is the quality score of DEVLAB?
What is the revenue of Dev Labtech Venture Limited (DEVLAB)?
What is the net profit margin of DEVLAB?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.